Use of Methylphenidate in Excessive Daytime Sleepiness in Alzheimer’s Patients Treated with Donepezil: Case Series

Leszek Bidzan,1 Mariola Bidzan2 1Department of Developmental Psychiatry, Psychotic and Geriatric Disorders, Medical University of Gdansk, Gdansk, Poland; 2Institute of Psychology, University of Gdansk, Gdansk, PolandCorrespondence: Mariola Bidzan Email mariola.bidzan@ug.edu.plAbstract: Sleep disorde...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Bidzan L, Bidzan M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	sleep disorders alzheimer's disease treatment methylphenidate Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/dbf1584f61dd4dd1995323ec09b232ec
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:dbf1584f61dd4dd1995323ec09b232ec
record_format	dspace
spelling	oai:doaj.org-article:dbf1584f61dd4dd1995323ec09b232ec2021-12-02T12:19:31ZUse of Methylphenidate in Excessive Daytime Sleepiness in Alzheimer’s Patients Treated with Donepezil: Case Series1178-2021https://doaj.org/article/dbf1584f61dd4dd1995323ec09b232ec2020-11-01T00:00:00Zhttps://www.dovepress.com/use-of-methylphenidate-in-excessive-daytime-sleepiness-in-alzheimerrsq-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Leszek Bidzan,1 Mariola Bidzan2 1Department of Developmental Psychiatry, Psychotic and Geriatric Disorders, Medical University of Gdansk, Gdansk, Poland; 2Institute of Psychology, University of Gdansk, Gdansk, PolandCorrespondence: Mariola Bidzan Email mariola.bidzan@ug.edu.plAbstract: Sleep disorders, inversion of sleep rhythm, excessive daytime sleepiness, and sleeplessness at night are common in Alzheimer’s disease (AD). Sleep disorders in AD have a diverse pathogenesis and their incidence increases as the disease progresses. Some publications indicate possible beneficial effects of methylphenidate on sleep. We presented two cases of patients with diagnosed AD accompanied by sleep disorders which had a significant impact on their functioning. The pathogenesis of sleep disorders was different in those two cases. In both case studies, the use of methylphenidate brought an immediate clinical effect, improving sleep at night and functioning during the day.Keywords: sleep disorders, Alzheimer’s disease, treatment, methylphenidateBidzan LBidzan MDove Medical Pressarticlesleep disordersalzheimer's diseasetreatmentmethylphenidateNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 16, Pp 2677-2680 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	sleep disorders alzheimer's disease treatment methylphenidate Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	sleep disorders alzheimer's disease treatment methylphenidate Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Bidzan L Bidzan M Use of Methylphenidate in Excessive Daytime Sleepiness in Alzheimer’s Patients Treated with Donepezil: Case Series
description	Leszek Bidzan,1 Mariola Bidzan2 1Department of Developmental Psychiatry, Psychotic and Geriatric Disorders, Medical University of Gdansk, Gdansk, Poland; 2Institute of Psychology, University of Gdansk, Gdansk, PolandCorrespondence: Mariola Bidzan Email mariola.bidzan@ug.edu.plAbstract: Sleep disorders, inversion of sleep rhythm, excessive daytime sleepiness, and sleeplessness at night are common in Alzheimer’s disease (AD). Sleep disorders in AD have a diverse pathogenesis and their incidence increases as the disease progresses. Some publications indicate possible beneficial effects of methylphenidate on sleep. We presented two cases of patients with diagnosed AD accompanied by sleep disorders which had a significant impact on their functioning. The pathogenesis of sleep disorders was different in those two cases. In both case studies, the use of methylphenidate brought an immediate clinical effect, improving sleep at night and functioning during the day.Keywords: sleep disorders, Alzheimer’s disease, treatment, methylphenidate
format	article
author	Bidzan L Bidzan M
author_facet	Bidzan L Bidzan M
author_sort	Bidzan L
title	Use of Methylphenidate in Excessive Daytime Sleepiness in Alzheimer’s Patients Treated with Donepezil: Case Series
title_short	Use of Methylphenidate in Excessive Daytime Sleepiness in Alzheimer’s Patients Treated with Donepezil: Case Series
title_full	Use of Methylphenidate in Excessive Daytime Sleepiness in Alzheimer’s Patients Treated with Donepezil: Case Series
title_fullStr	Use of Methylphenidate in Excessive Daytime Sleepiness in Alzheimer’s Patients Treated with Donepezil: Case Series
title_full_unstemmed	Use of Methylphenidate in Excessive Daytime Sleepiness in Alzheimer’s Patients Treated with Donepezil: Case Series
title_sort	use of methylphenidate in excessive daytime sleepiness in alzheimer’s patients treated with donepezil: case series
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/dbf1584f61dd4dd1995323ec09b232ec
work_keys_str_mv	AT bidzanl useofmethylphenidateinexcessivedaytimesleepinessinalzheimerrsquospatientstreatedwithdonepezilcaseseries AT bidzanm useofmethylphenidateinexcessivedaytimesleepinessinalzheimerrsquospatientstreatedwithdonepezilcaseseries
_version_	1718394543291760640

Use of Methylphenidate in Excessive Daytime Sleepiness in Alzheimer&rsquo;s Patients Treated with Donepezil: Case Series

Ejemplares similares

Use of Methylphenidate in Excessive Daytime Sleepiness in Alzheimer’s Patients Treated with Donepezil: Case Series